During the past decade, Samara Regional Clinical Cardiological Dispensary conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samara Regional Clinical Cardiological Dispensary" #1 sponsor was "Actelion" with 5 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samara Regional Clinical Cardiological Dispensary" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Samara Regional Clinical Cardiological Dispensary" are "Cardiovascular Disease" (2 trials), "Hypertension, Pulmonary" (2 trials), "Juvenile Idiopathic Arthritis" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Samara Regional Clinical Cardiological Dispensary" in a lesser frequency.

Most popular intervention types in "Samara Regional Clinical Cardiological Dispensary" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Macitentan 10 mg" (2 trials), "Selexipag" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Samara Regional Clinical Cardiological Dispensary" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Samara Regional Clinical Cardiological Dispensary". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Samara Regional Clinical Cardiological Dispensary, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Samara Regional Clinical Cardiological Dispensary, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".